Loretta Tse

Dr. Loretta Tse is a Vice President at Tekla Capital Management LLC.
She is responsible for investment research and due diligence in the biotechnology, medical device, and diagnostic areas and serves as a member of the team responsible for making and executing on venture investments on behalf of the Funds.
She joined the firm in July 2015.
Previously, she ran a biotech consulting business and worked with various venture funds and start-up companies.
Prior to that, Dr. Tse was Managing Director, Technology Transfer and Industry Relations at Fred Hutchinson Cancer Research Center, where she ran an office that was responsible for protection and commercialization of research output and formation of start-up companies, was an Associate at Oxford Biosciences Partners, an early stage Life Sciences venture fund, and worked in business development at several early stage biotech companies prior to joining Oxford.
She was previously employed as a Director-Business Development by Mergen Ltd., and Business Development Manager by Strata BioSciences, Inc. Dr. Tse holds a Bachelor of Science in Biochemistry from University of California, Davis and a PhD in Pharmacology from Johns Hopkins School of Medicine.